Bryan Norrie is a partner at Aitken Klee LLP in the Ottawa office.
Bryan specializes in the litigation of pharmaceutical and biotechnology patents. He has a M.Sc. in Neuroscience and Biomedical Engineering, and is a registered Canadian patent agent. Bryan enjoys combining his technical and legal expertise to identify creative approaches to complex issues, and he has been ranked or recognized in many leading industry publications, where he has been hailed as a “strong litigator” and “exceptional lawyer” who “has tremendous experience”.
Bryan regularly appears in the Federal Court of Canada and Federal Court of Appeal in trials, application hearings, motions and appeals.
- Bar Admission, Ontario – 2007
- Registered Patent Agent, Canada – 2009
- BCL/LLB 2006 – McGill University – with distinction
- MSc 2003 (Neuroscience and Biomedical Engineering) – University of Alberta
- BSc 2000 (Physiology, 1st class honours) – University of Alberta
Recent reported decisions:
- Janssen Inc. v. Apotex Inc., 2021 FC 7
- Teva Canada Innovation v. Pharmascience Inc., 2020 FC 1158
- Natco Pharma (Canada) Inc. v. Canada (Health), 2020 FC 788
- Natco Pharma (Canada) Inc. v. Canada (Health), 2020 FC 618
- Teva Canada Innovation v. Pharmascience Inc., 2019 FC 1394
- Millennium Pharmaceuticals Inc. v. Teva Canada Limited, 2019 FCA 273
- Teva Canada Limited v. Janssen Inc., 2018 FC 754
Other recent notable litigation:
- T-353-20 and T-1581-20 – Celgene v Natco (pomalidomide)
- T-1187-19 – Bayer v Dr Reddy’s (rivaroxaban)
- T-1527-18 and T-1529-18 – Celgene v Natco (lenalidomide)
- Chambers and Partners (2021) – hailed by commentators as a “strong litigator” and an “exceptional lawyer.”
- IAM Patent 1000 – ranked as one of the world’s leading patent practitioners (2015-2021) – “has tremendous experience”
- Legal 500 (Canada) – recognized as one of Canada’s leading intellectual property practitioners (2019)
- Who’s Who Legal – Life Sciences 2021 (Patent Litigation)
- Best Lawyers Global Business Edition 2020 (Intellectual Property Law)
- Patent Litigation, Intellectual Property Litigation: Forms and Precedents (Paul Lomic, ed., 2016, LexisNexis Canada)
- Utility, Intellectual Property Law Benchbook (Donald M. Cameron, ed., 2019, Carswell).
- Contributor: The Lawyer’s Daily (LexisNexis Canada, 2018-2019)
- Panelist: 2018 CBA IP Professional Development Symposium
- Speaker: Intellectual Property Litigation, Ontario Bar Association, November 22, 2016
- Reduced functional recovery by delaying motor training after spinal cord injury. Norrie BA, Nevett-Duchcherer JM, Gorassini MA. J Neurophysiol. 2005 Jul;94(1):255-6
- In-situ crosslinking thermoreversible polymers for cell entrapment. Norrie B, Jalil A, Lakey JR, Rajotte RV, Uludag H. Adv Exp Med Biol. 2004;553:19-28.
- Engineering temperature-sensitive poly(N-isopropylacrylamide) polymers as carriers of therapeutic proteins. Uludag H, Norrie B, Kousinioris N, Gao T. Biotechnol Bioeng. 2001 Jun 20;73(6):510-21.
- Intellectual Property Institute of Canada
- Canadian Bar Association